Citadel SA Multi Factor Equity H4 Fund (B1) - CSMHB1 - Click a Unit Trust

Click a Unit Trust

JUMP TO: Fund objective Fund data Allocations List shares

-0.01 / 0%

13.8022

NAV (ZAR) on 2024/11/14

NAV (ZAR) on 2024/11/13	13.8023
52 week high on 2024/09/26	14.8008
52 week low on 2024/01/17	12.1020
Total Expense Ratio on 2024/09/30	0.96
Total Expense Ratio (performance fee) on	0

	NAV	Incl Dividends
1 month change	-2.73%	-2.73%
3 month change	1.62%	4.23%
6 month change	5.11%	7.81%
1 year change	13.11%	17.91%
5 year change	6.64%	10.84%
10 year change	0%	0%
Price data is updated once a day. Unit trust and ETF performances for periods greater than 12 months are annualised.

COMPARE INSTRUMENTS

Here is a list of JSE shares held in this Unit Trust. These tables reflect changes in holdings over two quarters, but do not show where a fund has completely sold a holding during the latest quarter.

Citadel SA Multi Factor Equity H4 Fund

Fund managed by H4 Collective Investments (RF) Pty Ltd.

Citadel SA Multi Factor Equity H4 Fund (B1) - CSMHB1

Holdings	Jun 2024		Mar 2024		Unit change	Value change (R'000s)	% of Fund	manco	link	code
Holdings	# Units	Value (R'000s)	# Units	Value (R'000s)	Unit change	Value change (R'000s)	% of Fund	manco	link	code
Absa Group Ltd.	185,039	293,194.300	127,103	188,277.670	57,936	104,916.630	2.6047		Absa Group Ltd. - JSE:ABG	ABG
Anglo American plc	69,038	398,004.070	38,680	179,923.890	30,358	218,080.180	3.5358		Anglo American plc - JSE:AGL	AGL
AngloGold Ashanti plc	28,086	129,131.000	28,086	118,716.710	0	10,414.290	1.1472		AngloGold Ashanti plc - JSE:ANG	ANG
Anheuser-Busch InBev SA/NV	7,657	81,406.930	7,657	88,573.880	0	-7,166.950	0.7232		Anheuser-Busch InBev SA/NV - JSE:ANH	ANH
Aspen Pharmacare Holdings Ltd.	73,011	170,341.960	33,838	74,233.800	39,173	96,108.160	1.5133		Aspen Pharmacare Holdings Ltd. - JSE:APN	APN
Total

The free version only lists 5 shares. Subscribe to see the full list.

SUBSCRIBE NOW

The Citadel SA Multi Factor Equity H4 Fund is a specialist systematic equity portfolio, having the primary objectives of earning the rewards of taking exposure to known equity risk factors. It aims to allocate risk dynamically between such risk factors and explicity manage diversification, with the intended result being the production of higher risk-adjusted returns than those of the broad South African equity market.